Clear Street

💻 Join us for a webinar on the future of ETFs! 💻 The WFE and Clear Street are bringing together a panel of ETF experts to discuss the current trends, opportunities and pain points they're seeing in the space, as well as the regulatory implications post-election and a market outlook for 2025. Moderated by our Regulatory Affairs Manager, Charlie Ryder, we'll also hear from Thomas Bonville, Head of Derivative Sales at Clear Street, Alison Hennessy, Head of ETP Listings at Nasdaq, Matthew Tuttle, CEO and CIO of Tuttle Capital Management LLC and William Rhind, Founder and CEO of GraniteShares ETFs They'll drill down on how monetary policy, regulatory policies, inflation, and the new administration could impact the ETFs industry. 🖱️ Click here to register: https://bit.ly/41WWUDN

Yesterday, Ashley DeSimone, Clear Street’s Chief Marketing Officer, Claire Reilly, Director, Capital Introduction, and Jacinda Fahey, CEO of Clear Street UK and EU, hosted a table talk session with Tetiana Kyslytsyna, CAIA, UBS Hedge Fund Solutions, at 100 Women In Finance's "A Decade of Impact: Celebrating 10 Years of 100WF FundWomen" event at the NYSE. They explored shifts in hedge fund portfolio asset allocation in today’s market environment, offering valuable insights from a Capital Introduction perspective. Thank you to all the women who attended our table sessions and shared their knowledge during our insightful conversation. Jeanette Forkan, Sarah Finley, Kellan Brown

We are excited to announce the expansion of our recently launched equity research offering with the addition of Healthcare Equity Research.  Initially focused on the biotechnology sector, our expanded research offering complements our full suite of existing products and demonstrates our commitment to providing capabilities that align with our clients’ evolving needs.  To initiate coverage, Clear Street has appointed Kaveri Pohlman, PhD, MBA, and Bill Maughan, Ph.D., as Managing Directors and Senior Equity Analysts, reporting to Mara Goldstein, Director of Research. Healthcare coverage launch includes: • CARGO Therapeutics (Nasdaq: CRGX) • Century Therapeutics, Inc (Nasdaq: IPSC) • Cullinan Therapeutics (Nasdaq: CGEM) • Delcath Systems (Nasdaq: DCTH) • Enliven Therapeutics (Nasdaq: ELVN) • Erasca, Inc. (Nasdaq: ERAS) • Immatics (Nasdaq: IMTX) • Janux Therapeutics (Nasdaq: JANX) • MoonLake Immunotherapeutics (NASDAQ: MLTX) • Nuvation Bio (NYSE: NUVB) • Protagonist Therapeutics (Nasdaq: PTGX) • Y-mAbs Therapeutics, Inc. (Nasdaq: YMAB) Read the press release here: https://lnkd.in/etptvWxb

Clear Street is thrilled to announce the formal launch of Clear Street UK following FCA approval and the start of membership in the London Metal Exchange (‘LME’) as a Category 1 Member.  This is a pivotal step in Clear Street’s global expansion plans as we build out our vision to empower clients across all geographies and all financial products. Read the press release here: https://lnkd.in/eCE-nzTg

Congratulations, Matthew C., on reaching your five-year anniversary at Clear Street this November! This achievement speaks to your dedication and the positive impact you've made on our team. Here's to many more years of success and continued growth ahead! Interested in joining our team? Visit: https://lnkd.in/eQ6P6dZn

Clear Street is excited to attend FIA, Inc.'s Futures & Options Expo in Chicago next week, November 18-20. Join Eunice Pareja, Managing Director, Clearing Operations, on Tuesday, November 19th at 2:25 pm for "The Options Explosion" panel, an insightful discussion exploring the growth of options, their role as a hedging tool, their impact on the market and more. Also attending? Reach out to Eunice Pareja and Brent Posner to connect!

Clear Street is thrilled to announce the launch of our Equity Research Group, led by Mara Goldstein, Director of Research.  This new service presents comprehensive market analysis and investment insights for our growing institutional client base.  Initial sectors under coverage are Disruptive Technology and Energy Transition, covered by Brian Dobson and Tim Moore, CFA, respectively. Mara Goldstein, Kaveri Pohlman, PhD, MBA and Bill Maughan, Ph.D. will provide Healthcare research coverage. Specific coverage launched includes: Disruptive Technology: Bitfarms Ltd/Canada (Nasdaq: BITF), Bit Digital | NASDAQ: BTBT, CleanSpark Inc (Nasdaq: CLSK), MARA Holdings Inc (Nasdaq: MARA), Riot Platforms, Inc. (Nasdaq: RIOT) and TeraWulf Inc (Nasdaq: WULF). Energy Transition: Altus Power, Inc. (NYSE: AMPS), Bloom Energy Corp (NYSE: BE), Montauk Renewables, Inc. (Nasdaq: MNTK), Plug Power Inc. (Nasdaq: PLUG), Sunrun Inc. (Nasdaq: RUN) and Willdan Group (Nasdaq: WLDN). We look forward to providing new opportunities within these sectors for our clients to capitalize on innovation while strengthening our position in the market. Read the press release here: https://lnkd.in/evWF66TS

Join Patrick Travers, CEO of Clear Street Derivatives, next Wednesday, November 13th, on "The Evolving Role Of The ETF Custodian" panel at The ETP Forum hosted by ETF Global. Gain insights from leading industry experts on the issues, challenges and supporting services shaped by the rapid growth of Exchange-Traded Funds. Learn more and register: https://etpforum.org/

We are thrilled to have Ed Tilly, President and CEO-Elect, speaking at the 2024 SIFMA Market Structure Conference on Wednesday, November 6th during the 9:40 AM Fireside Chat! This essential capital markets event will explore the industry's landscape, election day news, regulatory and clearing updates, what's driving options customers and much more. Explore the program and register to join Ed on November 6th: https://lnkd.in/eb3U3hSk

Congratulations to Charles Ross and Joseph Gentile on celebrating 5 years at Clear Street this October! Your hard work and commitment to our journey continues to push us forward. Here’s to many more years of success together! Interested in joining the team? Visit: https://lnkd.in/eQ6P6dZn